Patients with systemic sclerosis present with varying clinical features, have different responses to therapy, and end up with different outcomes. Categorizing patients improves disease management. A new study now proposes that patients with systemic sclerosis and overlapping features of another connective tissue disease might form a distinct disease subset.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202–205 (1988).
Gliddon, A. E. et al. Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis. J. Rheumatol. 38, 702–705 (2011).
Meyer, O. C., Fertig, N., Lucas, M., Somogyi, N., & Medsger, T. A. Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J. Rheumatol. 34, 104–109 (2007).
Moinzadeh, P. et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204487.
Pakozdi, A. et al. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J. Rheumatol. 38, 2406–2409 (2011).
Poormoghim, H., Lucas, M., Fertig, N. & Medsger, T. A. Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum. 43, 444–451 (2000).
Marangoni, R. G. et al. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort. Rheumatology (Oxford) 52, 1520–1524 (2013).
Joseph, C. G. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343, 152–157 (2014).
Milano, A. et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS ONE 3, e2696 (2008).
Hinchcliff, M. et al. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J. Invest. Dermatol. 133, 1979–1989 (2013).
Acknowledgements
The authors' work is supported by grants from the NIH (AR42309 and HD55884).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Varga, J., Hinchcliff, M. Systemic sclerosis: beyond limited and diffuse subsets?. Nat Rev Rheumatol 10, 200–202 (2014). https://doi.org/10.1038/nrrheum.2014.22
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.22
This article is cited by
-
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography
Rheumatology International (2023)
-
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis
Scientific Reports (2022)
-
Systemic sclerosis
Nature Reviews Disease Primers (2015)
-
Recent Advances in the Genetics of Systemic Sclerosis: Toward Biological and Clinical Significance
Current Rheumatology Reports (2015)
